Search | TVST | ARVO Journals

Showing 1 – 20 of 34

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles December 2020

Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium/Choroid in Rabbits

PDF

Viral S. Kansara; Mark Cooper; Ozge Sesenoglu-Laird; Leroy Muya; Robert Moen; Thomas A. Ciulla

Trans. Vis. Sci. Tech.. 2020; 9(13):21. doi: https://doi.org/10.1167/tvst.9.13.21

Articles October 2020

Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders

PDF

Chen-rei Wan; Barry Kapik; Charles C. Wykoff; Christopher R. Henry; Mark R. Barakat; Milan Shah; Rafael V. Andino; Thomas A. Ciulla
TAGS: injections, needles, retinal diseases, subcutaneous injections, surveys
Trans. Vis. Sci. Tech.. 2020; 9(11):27. doi: https://doi.org/10.1167/tvst.9.11.27

ARVO Annual Meeting Abstract June 2020

Treatment Burden and Visual Outcomes in Neovascular Age-Related Macular Degeneration (AMD)

Saira Khanna; Rahul Komati; David Aaron Eichenbaum; Ishani Hariprasad; Thomas A Ciulla; Seenu Hariprasad

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4200. doi:

ARVO Annual Meeting Abstract June 2020

A Lean Six Sigma Approach to Scleral Buckling Surgery

Michael Gemayel; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4380. doi:

ARVO Annual Meeting Abstract June 2020

Area of Disorganization of the Retinal Inner Layers (DRIL) as a Quantitative Biomarker in Eyes with Diabetic Macular Edema

Swetha Bindu Velaga; Muneeswar Gupta Nittala; Jyotsna Maram; Thomas A Ciulla; Michael S Ip; Srinivas Sadda

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4859. doi:

ARVO Annual Meeting Abstract June 2020

Suprachoroidal Delivery of Suspensions of Tyrosine Kinase Inhibitor, Complement Inhibitor, and Corticosteroid: Preclinical and Clinical Correlates

Debra A Goldstein; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2898. doi:

ARVO Annual Meeting Abstract June 2020

Ocular Pharmacokinetics and Safety of Suprachoroidal A01017, Small Molecule Complement Inhibitor, Injectable Suspension in Rabbits

Shelley E Hancock; Avinash Phadke; Viral Kansara; David Boyer; Jose Rivera; Christopher Marlor; Steven Podos; Jason Wiles; Rick McElheny; Thomas A Ciulla; Mingjun Huang; Mark Cartwright

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3694. doi:

ARVO Annual Meeting Abstract June 2020

Correlation of Best Corrected Visual Acuity and Central Subfield Thickness in Macular Edema Due to Retinal Vein Occlusion, Diabetic Retinopathy and Uveitis

Dilraj Grewal; Thomas A Ciulla; Barry Kapik

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3239. doi:

ARVO Annual Meeting Abstract June 2020

Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Macular Edema Due to Retinal Vein Occlusion: A Real World Analysis of 12,214 Eyes.

Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3523. doi:

ARVO Annual Meeting Abstract July 2019

A theoretical study of vascular configurations of retinal capillary plexi based on OCTA data

Greta Chiaravalli; Giovanna Guidoboni; Riccardo Sacco; Thomas A Ciulla; Alon Harris

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):149. doi:

ARVO Annual Meeting Abstract July 2019

Quantifying retinal and choroidal contributions to macular oxygenation: a theoretical approach

Alice Chandra Verticchio Vercellin; Alon Harris; Thomas A Ciulla; Greta Chiaravalli; Riccardo Sacco; Brent A Siesky; Ingrida Januleviciene; Giovanna Guidoboni

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):28. doi:

ARVO Annual Meeting Abstract July 2019

Estimation of Impact of RPE65- Mediated Inherited Retinal Disease on Quality of Life

Thomas A Ciulla; Andrew Lloyd; Natalia Piglowska; Sarah Pitluck; Scott Johnson; Marric Buessing; Thomas O'Connell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4466. doi:

ARVO Annual Meeting Abstract July 2019

Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Diabetic Macular Edema: A “Real World” Analysis in 28,456 Eyes

Ashley Neiweem; Thomas A Ciulla; Alon Harris

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3654. doi:

ARVO Annual Meeting Abstract July 2018

Optic nerve head morphology at baseline is associated with changes in capillary blood flow in diabetic patients with open angle glaucoma after four years.

Alice Chandra Verticchio Vercellin; Alon Harris; Brent A Siesky; David Camp; Aaditya Shah; Aditya Belamkar; Sunu Mathew; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5084. doi:

ARVO Annual Meeting Abstract July 2018

In open angle glaucoma patients with diabetes mellitus longitudinal changes in central corneal thickness are associated with changes in optic nerve head morphology.

David Camp; Alon Harris; Thomas A Ciulla; Alice Chandra Verticchio Vercellin; Aaditya Shah; Priyanka Parekh; Marie-Caroline Antheriou; Brent A Siesky

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5895. doi:

ARVO Annual Meeting Abstract July 2018

Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular AMD Patients: A “Real World” Analysis in 49,485 Eyes

Thomas A Ciulla; John S Pollack; David Williams

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1623. doi:

ARVO Annual Meeting Abstract July 2018

Relationship between visual function and changes in optic nerve head parameters in open angle glaucoma patients with diabetes mellitus

June Geng; Alon Harris; Thomas A Ciulla; Alice Chandra Verticchio Vercellin; Aaditya Shah; David Camp; George Eckert; Brent A Siesky

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2094. doi:

ARVO Annual Meeting Abstract June 2017

A Meta-Analysis of Baseline Characteristics and Anti-VEGF Frequency for Neovascular AMD: Visual Acuity Gains are Influenced by Injection Frequency

Rehan M Hussain; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):421. doi:

ARVO Annual Meeting Abstract June 2017

Microbial Spectrum and Antibacterial Susceptibility of Vitreous Cultures in a Tertiary Referral Center in the Midwestern United States

Brent Aebi; Peter Bracha; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5500. doi:

ARVO Annual Meeting Abstract June 2017

Real World U.S. Outcomes of Anti-VEGF Therapy in Diabetic Macular Edema

Thomas A Ciulla; David F. Williams

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2025. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium/Choroid in Rabbits

Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders

Treatment Burden and Visual Outcomes in Neovascular Age-Related Macular Degeneration (AMD)

A Lean Six Sigma Approach to Scleral Buckling Surgery

Area of Disorganization of the Retinal Inner Layers (DRIL) as a Quantitative Biomarker in Eyes with Diabetic Macular Edema

Suprachoroidal Delivery of Suspensions of Tyrosine Kinase Inhibitor, Complement Inhibitor, and Corticosteroid: Preclinical and Clinical Correlates

Ocular Pharmacokinetics and Safety of Suprachoroidal A01017, Small Molecule Complement Inhibitor, Injectable Suspension in Rabbits

Correlation of Best Corrected Visual Acuity and Central Subfield Thickness in Macular Edema Due to Retinal Vein Occlusion, Diabetic Retinopathy and Uveitis

Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Macular Edema Due to Retinal Vein Occlusion: A Real World Analysis of 12,214 Eyes.

A theoretical study of vascular configurations of retinal capillary plexi based on OCTA data

Quantifying retinal and choroidal contributions to macular oxygenation: a theoretical approach

Estimation of Impact of RPE65- Mediated Inherited Retinal Disease on Quality of Life

Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Diabetic Macular Edema: A “Real World” Analysis in 28,456 Eyes

Optic nerve head morphology at baseline is associated with changes in capillary blood flow in diabetic patients with open angle glaucoma after four years.

In open angle glaucoma patients with diabetes mellitus longitudinal changes in central corneal thickness are associated with changes in optic nerve head morphology.

Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular AMD Patients: A “Real World” Analysis in 49,485 Eyes

Relationship between visual function and changes in optic nerve head parameters in open angle glaucoma patients with diabetes mellitus

A Meta-Analysis of Baseline Characteristics and Anti-VEGF Frequency for Neovascular AMD: Visual Acuity Gains are Influenced by Injection Frequency

Microbial Spectrum and Antibacterial Susceptibility of Vitreous Cultures in a Tertiary Referral Center in the Midwestern United States

Real World U.S. Outcomes of Anti-VEGF Therapy in Diabetic Macular Edema

To View More...

You must be signed into an individual account to use this feature.